| Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia SP Treon, CK Tripsas, K Meid, D Warren, G Varma, R Green, ... The New England Journal of Medicine 372 (15), 1430-1440, 2015 | 1014 | 2015 |
| Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma K Dunleavy, S Pittaluga, LS Maeda, R Advani, CC Chen, J Hessler, ... The New England Journal of Medicine 368 (15), 1408-1416, 2013 | 624 | 2013 |
| Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021 | 101 | 2021 |
| A Prospective Multicenter Study Of The Bruton’s Tyrosine Kinase Inhibitor Ibrutinib In Patients With Relapsed Or Refractory Waldenstrom’s Macroglobulinemia SP Treon, CK Tripsas, G Yang, Y Cao, L Xu, Z Hunter, SJ Cropper, ... Blood 122 (21), 251-251, 2013 | 68 | 2013 |
| Integration of patient-specific paranasal sinus computed tomographic data into a virtual surgical environment SS Parikh, S Chan, SK Agrawal, PH Hwang, CM Salisbury, BY Rafii, ... American Journal of Rhinology & Allergy 23 (4), 442-447, 2009 | 50 | 2009 |
| HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, AV Danilov, M Bower, ... Blood advances 5 (14), 2852-2862, 2021 | 37 | 2021 |
| Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study AS Zayac, AM Evens, A Danilov, SD Smith, D Jagadeesh, LA Leslie, ... Haematologica 106 (7), 1932, 2021 | 32 | 2021 |
| Modern principles in the management of nodular lymphocyte‐predominant Hodgkin lymphoma MA Spinner, G Varma, RH Advani British journal of haematology 184 (1), 17-29, 2019 | 28 | 2019 |
| Outcomes of patients with newly-diagnosed Burkitt lymphoma (BL) and central nervous system (CNS) involvement treated in the modern era: A multi-institutional real-world analysis A Zayac, AM Evens, A Stadnik, SD Smith, D Jagadeesh, LA Leslie, C Wei, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 14 | 2019 |
| Novel approaches in Waldenström macroglobulinemia MA Spinner, G Varma, RH Advani Hematology/Oncology Clinics 32 (5), 875-890, 2018 | 10 | 2018 |
| Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia and lymphoma G Varma, TP Johnson, RH Advani Clin Adv Hematol Oncol 14 (7), 543-554, 2016 | 8 | 2016 |
| Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma EM Boyle, P Blaney, JH Stoeckle, Y Wang, H Ghamlouch, D Gagler, ... Clinical Cancer Research 29 (19), 3901-3913, 2023 | 7 | 2023 |
| Novel agents in relapsed/refractory diffuse large B-cell lymphoma G Varma, J Goldstein, RH Advani Hematological oncology 41, 92-106, 2023 | 7 | 2023 |
| The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC) AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ... Blood 134 (Supplement_1), 397-397, 2019 | 5 | 2019 |
| Teclistamab Demonstrates Clinical Activity in Real-World Patients Ineligible for the Pivotal Majestec-1 Trial B Gordon, L Fogel, G Varma, MM Saldarriaga, J Ahn, A Aleman, J Caro, ... Blood 142, 4741, 2023 | 3 | 2023 |
| Prognostication, survival and treatment-related outcomes in HIV-associated Burkitt lymphoma (HIV-BL): a US and UK collaborative analysis JP Alderuccio, AJ Olszewski, AM Evens, GP Collins, A Danilov, M Bower, ... Blood 136, 49-50, 2020 | 3 | 2020 |
| Ibrutinib In Previously Treated Patients With Waldenström’s Macroglobulinemia Is Highly Active, Produces Durable Responses, And Is Impacted By MYD88 And CXCR4 Mutation Status S Treon, C Tripsas, K Meid, D Warren, G Varma, R Green, K Argyropoulos, ... Haematologica 100, 311-311, 2015 | 3 | 2015 |
| Hospital room sterilization using far-ultraviolet radiation: a pilot evaluation of the Sterilray device in an active hospital setting G Varma, P Savard, C Coles, T Ross, K Carroll, T Perl, A Labrique Infection Control and Hospital Epidemiology 34 (5), 536-538, 2013 | 3 | 2013 |
| Approach to High-Risk Multiple Myeloma X Chen, G Varma, F Davies, G Morgan Hematology/Oncology Clinics 38 (2), 497-510, 2024 | 2 | 2024 |
| Improved Risk Stratification With Addition Of Male Sex (S) To The Elderly International Prognostic Index (S-EIPI) For DLBCL Patients> 60 Years Treated With R-CHOP: An … RH Advani, F Hong, TM Habermann, H Li, BS Kahl, VA Morrison, ... Blood 122 (21), 3045-3045, 2013 | 2 | 2013 |
Elaine JaffeNational Cancer Institute在 mail.nih.gov 的电子邮件经过验证
